Search by Drug Name or NDC
NDC 70710-1247-01 VORICONAZOLE 10 mg/mL Details
VORICONAZOLE 10 mg/mL
VORICONAZOLE is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is VORICONAZOLE.
Product Information
| NDC | 70710-1247 |
|---|---|
| Product ID | 70710-1247_63f99ef1-dd00-4375-8baa-a06c2de48686 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | VORICONAZOLE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208983 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1247-01 (70710124701)
| NDC Package Code | 70710-1247-1 |
|---|---|
| Billing NDC | 70710124701 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1247-1) / 20 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2019-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |